Drugs
Trump's Executive Order on Drug Prices: A Look at its Effectiveness and Implications
The Trump administration has signed an executive order aiming to cut down drug prices, sending letters to major pharmaceutical companies, including AbbVie, Amgen, and Pfizer, to comply. However, experts emphasize that the administration's ability to lower costs is limited, and the effort is essentially price control. The executive